Nominated for President-Elect Position
Carl D. Mottram, RRT, RPFT, FAARC, is the Director of the Mayo Clinic Pulmonary Function Laboratories and Pulmonary Rehabilitation Program, and holds the academic rank of Associate Professor of Medicine at the Mayo Clinic College of Medicine in Rochester, Minnesota. He is a graduate of the Mayo Clinic’s Respiratory Therapist program and currently serves as adjunct professor for the Mayo Clinic/University of Minnesota program. He is also the former Chairholder of the American Association for Respiratory Care’s Clinical Practice Guideline Committee. Mr. Mottram has served in numerous roles with CLSI, including serving as a member of various working groups; Vice Chairholder, and then Chairholder of the Consensus Committee on Quality Systems and Laboratory Practices; Board of Directors member; and Secretary of the Board of Directors. He currently serves as the Treasurer on the Executive Committee of the CLSI Board of Directors. Mr. Mottram is also a member of the Board of Trustees for the National Board for Respiratory Care and serves as a consultant to the Diagnostic Accreditation Program of British Columbia. Mr. Mottram is a recognized expert in the field of pulmonary diagnostics and is the author and editor of the definitive textbook in the field. He has published numerous abstracts, articles, and book chapters, and has given hundreds of lectures at national and international meetings.
Nominated for Treasurer Position
Bio-Rad Laboratories, Inc.
Maxfield Williams is the Director of Global Marketing at Bio-Rad Laboratories, Quality Systems Division, in Irvine, California. Mr. Williams has more than 19 years of global experience in clinical laboratory advocacy, accreditation, standards development, education, and quality improvement. Previous work with CLSI includes serving as a member of the Global Advisory/Global Programs Committee; member of the Leadership Conference Steering/Planning Committee; member of the US Technical Advisory Group to International Organization for Standardization Technical Committee (ISO/TC) 212 Working Group 1; contributor to numerous documents (including GP27); and observer on several CLSI Consensus Committees, including Evaluation Protocols, General Laboratory, and Quality Systems and Laboratory Practices. Mr. Williams received an MPA in Health Care Policy and Economics from the University of Washington’s Daniel J. Evans School of Public Affairs, and a BA in International Studies from the University of Washington’s Henry M. Jackson School of International Studies in Seattle.
Nominated for Secretary Position
Arizona State Public Health Laboratory
Victor Waddell, PhD, is currently the Laboratory Director of the Arizona State Public Health Laboratory in Phoenix, Arizona, USA. He earned his PhD in Molecular Biology and Genetics at Queen’s University Belfast, Northern Ireland. Dr. Waddell’s other degrees include an MS in Environmental Sciences and a BS in Biological Sciences, also from Queen’s University Belfast. Dr. Waddell has published many journal articles and co-authored book chapters relating to both public health and molecular biology.
Dr. Waddell has worked for the Arizona State Public Health Laboratory since 2001 and was appointed as Laboratory Director in May 2004. As Laboratory Director, he is responsible for overseeing the entire laboratory, including the Analytical Chemistry, Microbiology, Newborn Screening, BioEmergency Response, and Chemical Emergency Response Sections at the state laboratory. Dr. Waddell was part of the design build team that led the development and planning of the new Arizona State Public Health Laboratory. Dr. Waddell served a three-year term as a Member-at-Large on the Association of Public Health Laboratories (APHL) Board of Directors from 200 6–2009 and served as APHL President from 2011–2012. Dr. Waddell currently serves on several APHL committees and is the Co-Chair for the Joint Leadership Committee of the Laboratory Response Network formed by the Centers for Disease Control and Prevention, APHL, and the Federal Bureau of Investigation in 1999.
Nominated for Director (Government Constituency) Position
Centers for Disease Control and Prevention
Nancy Anderson, MMSc, MT(ASCP), is Chief of the Laboratory Standards Practice Branch, Division of Laboratory Systems at the Centers for Disease Control and Prevention (CDC). She has been in this role since 2008, managing a number of CDC’s responsibilities under the Clinical Laboratory Improvement Amendments (CLIA) program that oversees medical laboratory testing in the United States, in collaboration with the Centers for Medicare & Medicaid Services and the US Food and Drug Administration. Before this position, she served in the Branch for 15 years and has contributed to developing quality standards for approximately 10 CLIA regulations and several guidelines promoting good laboratory practices. Ms. Anderson’s clinical laboratory experience includes her work in hospital laboratories in New York, Florida, and Georgia, and in the CDC Special Bacteriology Reference Laboratory, and serving as the Coordinator for Emory University’s Master of Medical Science (MMSc) degree programs in the clinical laboratory sciences.
Ms. Anderson holds an MMSc degree in Clinical Microbiology from Emory University and is certified as a Medical Technologist by the American Society for Clinical Pathology. She is active in CLSI, where she chaired the subcommittee that developed M50, and was a member of the document development committee for M52. She was a member of the Consensus Committee on Microbiology (2009–2013) and is currently an advisor to that committee. Her other professional affiliations include serving as the CDC liaison to The Joint Commission Professional Technical Advisory Committee and the Association of Public Health Laboratories’ Laboratory Science and Standards Committee, and she is a member of the American Society for Microbiology.